三期試驗重點是保護力效果和罕見副作用。
免疫橋接是針對第二、三代疫苗。
#別偷換概念 #藥政防疫史墓碑
高端疫苗通過EUA  前衛生署副署長張鴻仁：藥政防疫史的里程碑
https://udn.com/news/story/122190/5612629
日藥廠也採免疫橋接 張鴻仁：食藥署決定是對的
h

政治與評論

健康與情感

職場產業

<div class="draft-block draft--p left">三期試驗重點是保護力效果和罕見副作用。<br>免疫橋接是針對第二、三代疫苗。<br><a href="https://www.facebook.com/hashtag/%E5%88%A5%E5%81%B7%E6%8F%9B%E6%A6%82%E5%BF%B5?__eep__=6&amp;__cft__[0]=AZULrhsXrHJJgyC6E4fwhPQfodXpiAlInqXsSgvukMdkh0RFATLo3sadN5_zzaSBhxkXZPKcNU2YI2RxK4ewOwJs16qEZCHxHsvwnBYH-r-6md1bbB9nXnzSrayMbuj-su-A2k6m5Cp7Do04_0_qHVr3CILKR5N16blbzRFYekPaCQ&amp;__tn__=*NK-R" target="_blank" class="draft--a">#別偷換概念</a> <a href="https://www.facebook.com/hashtag/%E8%97%A5%E6%94%BF%E9%98%B2%E7%96%AB%E5%8F%B2%E5%A2%93%E7%A2%91?__eep__=6&amp;__cft__[0]=AZULrhsXrHJJgyC6E4fwhPQfodXpiAlInqXsSgvukMdkh0RFATLo3sadN5_zzaSBhxkXZPKcNU2YI2RxK4ewOwJs16qEZCHxHsvwnBYH-r-6md1bbB9nXnzSrayMbuj-su-A2k6m5Cp7Do04_0_qHVr3CILKR5N16blbzRFYekPaCQ&amp;__tn__=*NK-R" target="_blank" class="draft--a">#藥政防疫史墓碑</a></div>
<div class="draft-block draft--p left">高端疫苗通過EUA  前衛生署副署長張鴻仁：藥政防疫史的里程碑<br><a href="https://udn.com/news/story/122190/5612629?fbclid=IwAR3TXHCm00v0Hv0lys_Ri1QxcusyH4vkznJ74cj_HKdRaCpzXKH925kmdMY" target="_blank" class="draft--a">https://udn.com/news/story/122190/5612629</a><br>日藥廠也採免疫橋接 張鴻仁：食藥署決定是對的<br><a href="https://udn.com/news/story/122190/5612629?fbclid=IwAR3OCmJF6gJEcFQRKx0sJU6HtZbXpg74AIE6CbhsNF-Dp0nZLszHbOPJJRQ" target="_blank" class="draft--a">https://udn.com/news/story/122190/5612629</a><br>觀點投書：日本疫苗「非」採用免疫橋接<br><a href="https://www.storm.mg/article/3823044?fbclid=IwAR3uczxLfjfy1cSuSlkOb7V1gWUQBMIJgJGlp-fRESa15YwaOROCE7wFLYE" target="_blank" class="draft--a">https://www.storm.mg/article/3823044</a><br>觀點投書：被偷換概念的免疫橋接<br><a href="https://www.storm.mg/article/3754565?fbclid=IwAR0HJEdOjauPTIFATGmNAE8EvLBJeP9IBkCQOc_7QYKj97bol3YIRXbbeec" target="_blank" class="draft--a">https://www.storm.mg/article/3754565</a></div>
<div class="draft--imgNormal draft-block"><div><div style="height:657px" class="image-block-prerender" data-src="https://images.vocus.cc/e19ed8fc-23c1-46d5-a09d-c4bf85b45a07.jpg" data-width="657" data-height="1024" data-position="center"></div><figcaption class="imageCaption draft-block" style="cursor:text;display:block"></figcaption></div></div>
<div class="draft-block draft--p left"></div>

<p>三期試驗重點是保護力效果和罕見副作用。<br>
免疫橋接是針對第二、三代疫苗。<br>
<a href="https://www.facebook.com/hashtag/%E5%88%A5%E5%81%B7%E6%8F%9B%E6%A6%82%E5%BF%B5?__eep__=6&amp;__cft__[0]=AZULrhsXrHJJgyC6E4fwhPQfodXpiAlInqXsSgvukMdkh0RFATLo3sadN5_zzaSBhxkXZPKcNU2YI2RxK4ewOwJs16qEZCHxHsvwnBYH-r-6md1bbB9nXnzSrayMbuj-su-A2k6m5Cp7Do04_0_qHVr3CILKR5N16blbzRFYekPaCQ&amp;__tn__=*NK-R">#別偷換概念</a> <a href="https://www.facebook.com/hashtag/%E8%97%A5%E6%94%BF%E9%98%B2%E7%96%AB%E5%8F%B2%E5%A2%93%E7%A2%91?__eep__=6&amp;__cft__[0]=AZULrhsXrHJJgyC6E4fwhPQfodXpiAlInqXsSgvukMdkh0RFATLo3sadN5_zzaSBhxkXZPKcNU2YI2RxK4ewOwJs16qEZCHxHsvwnBYH-r-6md1bbB9nXnzSrayMbuj-su-A2k6m5Cp7Do04_0_qHVr3CILKR5N16blbzRFYekPaCQ&amp;__tn__=*NK-R">#藥政防疫史墓碑</a></p>
<p>高端疫苗通過EUA &nbsp;前衛生署副署長張鴻仁：藥政防疫史的里程碑<br>
<a href="https://udn.com/news/story/122190/5612629?fbclid=IwAR3TXHCm00v0Hv0lys_Ri1QxcusyH4vkznJ74cj_HKdRaCpzXKH925kmdMY">https://udn.com/news/story/122190/5612629</a><br>
日藥廠也採免疫橋接 張鴻仁：食藥署決定是對的<br>
<a href="https://udn.com/news/story/122190/5612629?fbclid=IwAR3OCmJF6gJEcFQRKx0sJU6HtZbXpg74AIE6CbhsNF-Dp0nZLszHbOPJJRQ">https://udn.com/news/story/122190/5612629</a><br>
觀點投書：日本疫苗「非」採用免疫橋接<br>
<a href="https://www.storm.mg/article/3823044?fbclid=IwAR3uczxLfjfy1cSuSlkOb7V1gWUQBMIJgJGlp-fRESa15YwaOROCE7wFLYE">https://www.storm.mg/article/3823044</a><br>
觀點投書：被偷換概念的免疫橋接<br>
<a href="https://www.storm.mg/article/3754565?fbclid=IwAR0HJEdOjauPTIFATGmNAE8EvLBJeP9IBkCQOc_7QYKj97bol3YIRXbbeec">https://www.storm.mg/article/3754565</a></p>
<p><br></p>
<p><br></p>

三期試驗重點是保護力效果和罕見副作用。
免疫橋接是針對第二、三代疫苗。
#別偷換概念 #藥政防疫史墓碑

高端疫苗通過EUA  前衛生署副署長張鴻仁：藥政防疫史的里程碑
https://udn.com/news/story/122190/5612629
日藥廠也採免疫橋接 張鴻仁：食藥署決定是對的
https://udn.com/news/story/122190/5612629
觀點投書：日本疫苗「非」採用免疫橋接
https://www.storm.mg/article/3823044
觀點投書：被偷換概念的免疫橋接
https://www.storm.mg/article/3754565